留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究

李基明,  张慧芬,  谢辉,  沈彤

downloadPDF
文章导航 > 药学实践与服务  > 2014 >  32(3): 222-224
李基明, 张慧芬, 谢辉, 沈彤. 布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究[J]. 药学实践与服务, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
引用本文: 李基明, 张慧芬, 谢辉, 沈彤. 布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究[J]. 药学实践与服务, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
shu
LI Jiming, ZHANG Huifen, XIE Hui, SHEN Tong. Clinic research on Saccharomyces boulardii in preventing and treating antibiotics associated diarrhea in infant pneumonia[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
Citation: LI Jiming, ZHANG Huifen, XIE Hui, SHEN Tong. Clinic research on Saccharomyces boulardii in preventing and treating antibiotics associated diarrhea in infant pneumonia[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
shu

布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究

doi: 10.3969/j.issn.1006-0111.2014.03.016

  • 厦门市妇幼保健院, 福建 厦门 361003

Clinic research on Saccharomyces boulardii in preventing and treating antibiotics associated diarrhea in infant pneumonia

  • Xiamen Maternal and Children's Hospital, Xiamen 361003, China

  • 摘要: 目的 探讨布拉酵母菌对婴幼儿肺炎继发抗生素相关腹泻(AAD)的防治作用。 方法 选择1个月至3岁婴幼儿肺炎住院患者302例,均静脉应用抗菌药物且连续治疗>5 d,排除慢性胃肠道疾病,随机分为对照组(A组,60例)、布拉酵母菌治疗组(B组,92例)和布拉酵母菌预防组(C组,150例)。入选患儿在抗感染治疗的同时, C组加用布拉酵母菌,B组继发腹泻后加用布拉酵母菌,观察各组患儿AAD的发生情况,比较分析各组疗效。 结果 C组患儿AAD发生率明显低于A、B组患儿;各组患儿继发腹泻严重程度差异无统计学意义(P>0.05);腹泻持续时间差异有统计学意义(P<0.001),其中布拉酵母菌预防组腹泻持续时间最短,治疗组次之,对照组最长;抗腹泻总有效率差异有统计学意义(P<0.05),A组抗腹泻总有效率不如C组,尚不能认为A组与B组、B组与C组间抗腹泻疗效有差别。 结论 婴幼儿肺炎继发AAD后,应用布拉酵母菌,可缩短腹泻病程;若预防性应用布拉酵母菌不仅能降低AAD的发病率,还能缩短腹泻病程,提高AAD治疗疗效,值得在临床工作中推广预防应用。
    Abstract: Objective To investigate the therapeutic effect of Saccharomyces boulardii on antibiotics associated diarrhea(AAD)in infant pneumonia. Methods 302 hospitalized infant patients (1 month-3 years) with pneumonia but without gastroenteric disease were selected, and antibiotics were administrated intravenously at least 5 continuous days for each patient. Patients were all given antibiotics and randomly divided into three groups: control group with no Saccharomyces boulardii administration (group A, 60 cases);Saccharomyces boulardii were applied as addition on the occurrence of diarrhea (group B, 92 cases), and Saccharomyces boulardii and antibiotics were co-administrated (group C, 150 cases). Incidences of AAD in all groups were carefully examined and differences of therapeutic effect between groups were compared and analyzed. Results The incidence of AAD in Group C was significantly lower than that in other groups. In term of diarrhea severity, no significant difference was observed in all groups (P>0.05). However, duration of diarrhea showed significant different between groups (P<0.001): group A with the longest duration and group C with the shortest. The results indicated that the total efficiency of anti-diarrhea in group C was significantly higher than that in control group (P<0.05).However, group B presented no significant difference compared with neither control group nor group C in term of therapeutic effect on diarrhea. Conclusion Administration of Saccharomyces boulardii Sachets could shorten the duration of diarrhea on the occurrence of AAD in infant pneumonia. According to our results, Saccharomyces boulardii was effective in both preventing the development of AAD and shortening duration of diarrhea, and therefore improved therapeutic effect on ADD.
  • [1] 胡亚美,江载芳. 诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:1204-1205.
    [2] 方鹤松.小儿腹泻病的诊断和治疗[J].实用儿科临床杂志,2011,26(19):1537-1540.
    [3] 陈永红,王 镭,王云亭.儿科疾病与疗效标准[M].上海:上海中医药大学出版社,2006:47-49.
    [4] Vaishnavi C, Kaur S, Singh K. Clostridium perfringens type A & antibiotic associated diarrhea[J].Indian J Med Res, 2005,122(1):52-56.
    [5] 吉大章,邹商群,熊 琴,等.布拉酵母菌预防小儿抗生素相关性腹泻的临床研究[J].中国医药,2009,4(10):818-819.
    [6] 刘保良,陈 玮.抗生素相关性腹泻及其预防治疗[J].临床合理用药杂志,2008,9(1):51-53.
    [7] 郑跃杰,黄志华,刘作义,等.微生态制剂儿科应用专家共识(2010 年10 月)[J].中国实用儿科杂志,2011,26(1):20-23.
    [8] Correa NB,Penna FJ,Lima FM,et al. Treatment of acute diarrhea with saccharomyces boulardii in infants[J]. J Pediatr Gastroenterol Nutr,2011,53( 5): 497-501.
    [9] Riaz M,Alam S,Malik A,et al. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: A double blind randomised controlled trial[J]. Indian J Pediatr,2012,79( 4): 478-482.
    [10] Jones K.Probiotics: preventing antibiotic associated diarrhea[J].J Spec Pediatr Nurs,2010,15( 2):160-162.
  • [1] 桂明珠, 李静, 李志玲.  儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
    [2] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
    [3] 戴菲菲, 傅翔, 陈琼年, 俞苏纯.  上海某二级医院革兰阴性菌流行特征的回顾性分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202305005
    [4] 徐飞, 陈瑾, 鲁育含, 李志勇.  肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
    [5] 史生辉, 石飞, 雷琼, 王亚峰, 吴雪花.  青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
    [6] 孙丹倪, 黄勇, 张嘉宝, 王培.  代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
    [7] 陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
    [8] 唐淑慧, 凤美娟, 薛智霞, 鲁桂华.  帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
    [9] 尹小娟, 台力丽, 肖俊峰, 季波.  铜绿假单胞菌合并按蚊伊丽莎白菌肺部感染的病例分析 . 药学实践与服务, 2024, 42(5): 223-226. doi: 10.12206/j.issn.2097-2024.202310042
    [10] 黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉.  耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2564
  • HTML全文浏览量:  277
  • PDF下载量:  83
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-07-09
  • 修回日期:  2014-01-03

布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究

doi: 10.3969/j.issn.1006-0111.2014.03.016
  • 厦门市妇幼保健院, 福建 厦门 361003
  • 收稿日期: 2013-07-09
  • 修回日期: 2014-01-03

摘要: 目的 探讨布拉酵母菌对婴幼儿肺炎继发抗生素相关腹泻(AAD)的防治作用。 方法 选择1个月至3岁婴幼儿肺炎住院患者302例,均静脉应用抗菌药物且连续治疗>5 d,排除慢性胃肠道疾病,随机分为对照组(A组,60例)、布拉酵母菌治疗组(B组,92例)和布拉酵母菌预防组(C组,150例)。入选患儿在抗感染治疗的同时, C组加用布拉酵母菌,B组继发腹泻后加用布拉酵母菌,观察各组患儿AAD的发生情况,比较分析各组疗效。 结果 C组患儿AAD发生率明显低于A、B组患儿;各组患儿继发腹泻严重程度差异无统计学意义(P>0.05);腹泻持续时间差异有统计学意义(P<0.001),其中布拉酵母菌预防组腹泻持续时间最短,治疗组次之,对照组最长;抗腹泻总有效率差异有统计学意义(P<0.05),A组抗腹泻总有效率不如C组,尚不能认为A组与B组、B组与C组间抗腹泻疗效有差别。 结论 婴幼儿肺炎继发AAD后,应用布拉酵母菌,可缩短腹泻病程;若预防性应用布拉酵母菌不仅能降低AAD的发病率,还能缩短腹泻病程,提高AAD治疗疗效,值得在临床工作中推广预防应用。

English Abstract

李基明, 张慧芬, 谢辉, 沈彤. 布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究[J]. 药学实践与服务, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
引用本文: 李基明, 张慧芬, 谢辉, 沈彤. 布拉酵母菌防治婴幼儿肺炎继发抗生素相关腹泻的临床研究[J]. 药学实践与服务, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
shu
LI Jiming, ZHANG Huifen, XIE Hui, SHEN Tong. Clinic research on Saccharomyces boulardii in preventing and treating antibiotics associated diarrhea in infant pneumonia[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
Citation: LI Jiming, ZHANG Huifen, XIE Hui, SHEN Tong. Clinic research on Saccharomyces boulardii in preventing and treating antibiotics associated diarrhea in infant pneumonia[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(3): 222-224. doi: 10.3969/j.issn.1006-0111.2014.03.016
shu

    全文HTML

参考文献 (10)

目录

    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计